Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
mRNA RSV vaccine
- Development stage
- Unknown
- Lead developer
- AIM Vaccine Co.
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The mRNA RSV vaccine is an investigational messenger RNA-based vaccine candidate developed by Ningbo Rong'an Biological Pharmaceutical, a subsidiary of AIM Vaccine. This vaccine is designed to prevent Respiratory Syncytial Virus (RSV) infection by delivering mRNA that encodes for a viral antigen, typically the prefusion form of the RSV fusion (F) protein. Upon administration, the recipient's cells use the mRNA instructions to produce the viral antigen, which then stimulates the immune system to generate neutralizing antibodies and cellular immune responses against the virus. As of 2024, the candidate is in Phase 1 clinical development.
- Other names
- messenger ribonucleic acid respiratory syncytial virus vaccine
02
Targets
RSV F (Respiratory syncytial virus fusion protein)
Beyond the preview
Go deeper on mRNA RSV vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on mRNA RSV vaccine.